Pharmacophore modeling, virtual screening, molecular docking and dynamics studies for the discovery of HER2-tyrosine kinase inhibitors: An in-silico approach
Gurubasavaraja Swamy Purawarga Matada(Drug Discovery Laboratory (Norway)), Nulgumnalli Manjunathaiah Raghavendra(Dayananda Sagar University), Prasad Sanjay Dhiwar(Mahatma Gandhi Mission Institute of Health Sciences), Nahid Abbas(Rajiv Gandhi University of Health Sciences), Abhishek Ghara(Unknown), Ekta Singh(Rajiv Gandhi University of Health Sciences), Rajesh B. Patil(Sinhgad Dental College and Hospital)
Cited by 17
Related Papers
Exploring the therapeutic mechanisms of <i>Cassia glauca</i> in diabetes mellitus through network pharmacology, molecular docking and molecular dynamics
|RSC Advances|2021|42
Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancer
|Journal of Biomolecular Structure and Dynamics|2021|37
DDR1 and DDR2: a review on signaling pathway and small molecule inhibitors as an anticancer agent
|Medicinal Chemistry Research|2021|35
Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies
|European Journal of Medicinal Chemistry|2024|32
An assessment of EGFR and HER2 inhibitors with structure activity relationship of fused pyrimidine derivatives for breast cancer: a brief review
|Journal of Biomolecular Structure and Dynamics|2023|28